禁煙・ニコチン依存解消の世界市場2023年-2027年

◆英語タイトル:Global Smoking Cessation and Nicotine De-addiction Market 2023-2027

Technavioが発行した調査報告書(IRTNTR40398-22)◆商品コード:IRTNTR40398-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年11月14日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テクナビオ社の本調査レポートでは、禁煙・ニコチン依存解消の世界市場規模が2023年から2027年の間に24529.75百万ドル成長すると見込んでおり、予測期間中の年平均成長率は12.59%になると予想しています。本レポートでは、世界の禁煙・ニコチン依存解消市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、流通チャネル別(ドラッグストア・小売業者、病院薬局、オンライン小売)分析、製品別(電子タバコ、ニコチン代替治療(NRT)、薬物治療)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、中国、カナダ、インド)分析、企業分析などを以下の構成でまとめております。本レポートには、Alchem International Pvt. Ltd.、Alkalon AS、Alvogen、Axcentria Pharmaceuticals、British American Tobacco Plc、Cambrex Corp.、CHEMNOVATIC Sp. z o.o. Sp. k、Cipla Ltd.、Dr Reddys Laboratories Ltd.、Enorama Pharma ABなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の禁煙・ニコチン依存解消市場規模:製品別
- ドラッグストア・小売業者チャネルの市場規模
- 病院薬局チャネルの市場規模
- オンライン小売チャネルの市場規模
・世界の禁煙・ニコチン依存解消市場規模:製品別
- 電子タバコの市場規模
- ニコチン代替治療(NRT)の市場規模
- 薬物治療の市場規模
・地域別状況
- 北米の禁煙・ニコチン依存解消市場規模
- ヨーロッパの禁煙・ニコチン依存解消市場規模
- アジアの禁煙・ニコチン依存解消市場規模
- その他地域の禁煙・ニコチン依存解消市場規模
- アメリカの禁煙・ニコチン依存解消市場規模
- ドイツの禁煙・ニコチン依存解消市場規模
- 中国の禁煙・ニコチン依存解消市場規模
- カナダの禁煙・ニコチン依存解消市場規模
- インドの禁煙・ニコチン依存解消市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テクナビオ社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 テクナビオ社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

Global Smoking Cessation And Nicotine De-addiction Market 2023-2027
Technavio has been monitoring the smoking cessation and nicotine de-addiction market and is poised to grow by $24529.75 mn from 2023-2027, accelerating at a CAGR of 12.59% during the forecast period. Our report on the smoking cessation and nicotine de-addiction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of online retailing, the increasing number of people trying to quit smoking, and growing health awareness among consumers.

Technavio’s smoking cessation and nicotine de-addiction market are segmented as below:

By Distribution Channel
• Drug stores and retailers
• Hospital pharmacies
• Online retail

By Product
• E-cigarette
• NRT
• Drug therapy

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the new marketing initiatives as one of the prime reasons driving the smoking cessation and nicotine de-addiction market growth during the next few years. Also, the rising number of organized retail outlets distributing nicotine patches and increasing availability through various distribution channels will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on smoking cessation and the nicotine de-addiction market covers the following areas:
• Smoking cessation and nicotine de-addiction market sizing
• Smoking cessation and nicotine de-addiction market forecast
• Smoking cessation and nicotine de-addiction market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smoking cessation and nicotine de-addiction market vendors that include Alchem International Pvt. Ltd., Alkalon AS, Alvogen, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. z o.o. Sp. k, Cipla Ltd., Dr. Reddys Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson, Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International, Qnovia, Tvape, and Walgreen Co. Also, the smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics

• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

• 4 Historic Market Size
o 4.1 Global smoking cessation and nicotine de-addiction market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global smoking cessation and nicotine de-addiction market 2017 – 2021 ($ million)
o 4.2 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Drug stores and retailers – Market size and forecast 2022-2027
o Exhibit 34: Chart on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
o 6.4 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 6.5 Online retail – Market size and forecast 2022-2027
o Exhibit 42: Chart on Online retail – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online retail – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online retail – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online retail – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)

• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 47: Chart on Product – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 49: Chart on Comparison by Product
o Exhibit 50: Data Table on Comparison by Product
o 7.3 E-cigarette – Market size and forecast 2022-2027
o Exhibit 51: Chart on E-cigarette – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on E-cigarette – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on E-cigarette – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on E-cigarette – Year-over-year growth 2022-2027 (%)
o 7.4 NRT – Market size and forecast 2022-2027
o Exhibit 55: Chart on NRT – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on NRT – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on NRT – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on NRT – Year-over-year growth 2022-2027 (%)
o 7.5 Drug therapy – Market size and forecast 2022-2027
o Exhibit 59: Chart on Drug therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Drug therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Drug therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Drug therapy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Product
o Exhibit 63: Market opportunity by Product ($ million)

• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 97: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 India – Market size and forecast 2022-2027
o Exhibit 101: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.12 UK – Market size and forecast 2022-2027
o Exhibit 105: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)

• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends

• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business

• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Alchem International Pvt. Ltd.
o Exhibit 116: Alchem International Pvt. Ltd. – Overview
o Exhibit 117: Alchem International Pvt. Ltd. – Product / Service
o Exhibit 118: Alchem International Pvt. Ltd. – Key offerings
o 12.4 Alkalon AS
o Exhibit 119: Alkalon AS – Overview
o Exhibit 120: Alkalon AS – Product / Service
o Exhibit 121: Alkalon AS – Key offerings
o 12.5 Alvogen
o Exhibit 122: Alvogen – Overview
o Exhibit 123: Alvogen – Product / Service
o Exhibit 124: Alvogen – Key offerings
o 12.6 British American Tobacco Plc
o Exhibit 125: British American Tobacco Plc – Overview
o Exhibit 126: British American Tobacco Plc – Business segments
o Exhibit 127: British American Tobacco Plc – Key news
o Exhibit 128: British American Tobacco Plc – Key offerings
o Exhibit 129: British American Tobacco Plc – Segment focus
o 12.7 Cambrex Corp.
o Exhibit 130: Cambrex Corp. – Overview
o Exhibit 131: Cambrex Corp. – Product / Service
o Exhibit 132: Cambrex Corp. – Key news
o Exhibit 133: Cambrex Corp. – Key offerings
o 12.8 Cipla Ltd.
o Exhibit 134: Cipla Ltd. – Overview
o Exhibit 135: Cipla Ltd. – Business segments
o Exhibit 136: Cipla Ltd. – Key news
o Exhibit 137: Cipla Ltd. – Key offerings
o Exhibit 138: Cipla Ltd. – Segment focus
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 139: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 140: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 141: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 142: Dr Reddys Laboratories Ltd. – Segment focus
o 12.10 Enorama Pharma AB
o Exhibit 143: Enorama Pharma AB – Overview
o Exhibit 144: Enorama Pharma AB – Product / Service
o Exhibit 145: Enorama Pharma AB – Key news
o Exhibit 146: Enorama Pharma AB – Key offerings
o 12.11 Imperial Brands Plc
o Exhibit 147: Imperial Brands Plc – Overview
o Exhibit 148: Imperial Brands Plc – Business segments
o Exhibit 149: Imperial Brands Plc – Key news
o Exhibit 150: Imperial Brands Plc – Key offerings
o Exhibit 151: Imperial Brands Plc – Segment focus
o 12.12 Japan Tobacco Inc.
o Exhibit 152: Japan Tobacco Inc. – Overview
o Exhibit 153: Japan Tobacco Inc. – Business segments
o Exhibit 154: Japan Tobacco Inc. – Key news
o Exhibit 155: Japan Tobacco Inc. – Key offerings
o Exhibit 156: Japan Tobacco Inc. – Segment focus
o 12.13 Johnson and Johnson
o Exhibit 157: Johnson and Johnson – Overview
o Exhibit 158: Johnson and Johnson – Business segments
o Exhibit 159: Johnson and Johnson – Key news
o Exhibit 160: Johnson and Johnson – Key offerings
o Exhibit 161: Johnson and Johnson – Segment focus
o 12.14 Perrigo Co. Plc
o Exhibit 162: Perrigo Co. Plc – Overview
o Exhibit 163: Perrigo Co. Plc – Business segments
o Exhibit 164: Perrigo Co. Plc – Key news
o Exhibit 165: Perrigo Co. Plc – Key offerings
o Exhibit 166: Perrigo Co. Plc – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 167: Pfizer Inc. – Overview
o Exhibit 168: Pfizer Inc. – Product / Service
o Exhibit 169: Pfizer Inc. – Key news
o Exhibit 170: Pfizer Inc. – Key offerings
o 12.16 Philip Morris International
o Exhibit 171: Philip Morris International – Overview
o Exhibit 172: Philip Morris International – Business segments
o Exhibit 173: Philip Morris International – Key offerings
o Exhibit 174: Philip Morris International – Segment focus
o 12.17 Tvape
o Exhibit 175: Tvape – Overview
o Exhibit 176: Tvape – Product / Service
o Exhibit 177: Tvape – Key offerings

• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global smoking cessation and nicotine de-addiction market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online retail – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online retail – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online retail – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online retail – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Chart on Product – Market share 2022-2027 (%)
Exhibits48: Data Table on Product – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Product
Exhibits50: Data Table on Comparison by Product
Exhibits51: Chart on E-cigarette – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on E-cigarette – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on E-cigarette – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on E-cigarette – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on NRT – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on NRT – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on NRT – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on NRT – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Drug therapy – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Drug therapy – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Drug therapy – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Drug therapy – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Product ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Alchem International Pvt. Ltd. – Overview
Exhibits117: Alchem International Pvt. Ltd. – Product / Service
Exhibits118: Alchem International Pvt. Ltd. – Key offerings
Exhibits119: Alkalon AS – Overview
Exhibits120: Alkalon AS – Product / Service
Exhibits121: Alkalon AS – Key offerings
Exhibits122: Alvogen – Overview
Exhibits123: Alvogen – Product / Service
Exhibits124: Alvogen – Key offerings
Exhibits125: British American Tobacco Plc – Overview
Exhibits126: British American Tobacco Plc – Business segments
Exhibits127: British American Tobacco Plc – Key news
Exhibits128: British American Tobacco Plc – Key offerings
Exhibits129: British American Tobacco Plc – Segment focus
Exhibits130: Cambrex Corp. – Overview
Exhibits131: Cambrex Corp. – Product / Service
Exhibits132: Cambrex Corp. – Key news
Exhibits133: Cambrex Corp. – Key offerings
Exhibits134: Cipla Ltd. – Overview
Exhibits135: Cipla Ltd. – Business segments
Exhibits136: Cipla Ltd. – Key news
Exhibits137: Cipla Ltd. – Key offerings
Exhibits138: Cipla Ltd. – Segment focus
Exhibits139: Dr Reddys Laboratories Ltd. – Overview
Exhibits140: Dr Reddys Laboratories Ltd. – Business segments
Exhibits141: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits142: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits143: Enorama Pharma AB – Overview
Exhibits144: Enorama Pharma AB – Product / Service
Exhibits145: Enorama Pharma AB – Key news
Exhibits146: Enorama Pharma AB – Key offerings
Exhibits147: Imperial Brands Plc – Overview
Exhibits148: Imperial Brands Plc – Business segments
Exhibits149: Imperial Brands Plc – Key news
Exhibits150: Imperial Brands Plc – Key offerings
Exhibits151: Imperial Brands Plc – Segment focus
Exhibits152: Japan Tobacco Inc. – Overview
Exhibits153: Japan Tobacco Inc. – Business segments
Exhibits154: Japan Tobacco Inc. – Key news
Exhibits155: Japan Tobacco Inc. – Key offerings
Exhibits156: Japan Tobacco Inc. – Segment focus
Exhibits157: Johnson and Johnson – Overview
Exhibits158: Johnson and Johnson – Business segments
Exhibits159: Johnson and Johnson – Key news
Exhibits160: Johnson and Johnson – Key offerings
Exhibits161: Johnson and Johnson – Segment focus
Exhibits162: Perrigo Co. Plc – Overview
Exhibits163: Perrigo Co. Plc – Business segments
Exhibits164: Perrigo Co. Plc – Key news
Exhibits165: Perrigo Co. Plc – Key offerings
Exhibits166: Perrigo Co. Plc – Segment focus
Exhibits167: Pfizer Inc. – Overview
Exhibits168: Pfizer Inc. – Product / Service
Exhibits169: Pfizer Inc. – Key news
Exhibits170: Pfizer Inc. – Key offerings
Exhibits171: Philip Morris International – Overview
Exhibits172: Philip Morris International – Business segments
Exhibits173: Philip Morris International – Key offerings
Exhibits174: Philip Morris International – Segment focus
Exhibits175: Tvape – Overview
Exhibits176: Tvape – Product / Service
Exhibits177: Tvape – Key offerings
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 禁煙・ニコチン依存解消の世界市場2023年-2027年(Global Smoking Cessation and Nicotine De-addiction Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆